Haoxi Health Technology Limited, a company based in Beijing, China, recently completed a public offering, raising $12 million. The offering included 4,000,000 units at a price of $3.00 per unit. Each unit comprised one share of Class A Ordinary Share, a Series A warrant, and a Series B warrant.
The company expressed gratitude for the support and recognition from the market as they continue to implement their business strategy. The funds raised from the offering will be used to support business expansion and technology investments in the healthcare industry.
The underwriter for the offering, EF Hutton LLC, has been granted an option to purchase an additional 600,000 units to cover over-allotment within 45 days of the closing date. EF Hutton is acting as the sole bookrunner for the offering.
Haoxi Health Technology Limited specializes in providing online marketing solutions to healthcare industry advertisers in China. The company’s growth is driven by the increasing popularity of news feed ads and the rapid growth of the healthcare sector. They offer online marketing solutions, particularly in online short video marketing, to help advertisers reach and engage customers on various popular platforms in China.
The registration statement related to the offering was filed with the U.S. Securities and Exchange Commission (SEC) and declared effective on September 19, 2024. The offering is being made through a prospectus, and interested parties can obtain a copy of the final prospectus from EF Hutton or the SEC’s website.
It’s important to note that this press release does not constitute an offer to sell or a solicitation to buy the mentioned securities. Any sale of these securities must comply with the securities laws of the relevant state or jurisdiction.
For further information, interested parties can contact the underwriter, EF Hutton LLC, or the investor relations firm, WFS Investor Relations Inc. The company urges investors to exercise caution when relying on forward-looking statements, as they involve risks and uncertainties that may cause actual results to differ from expectations.
In conclusion, Haoxi Health Technology Limited’s successful public offering reflects the confidence and support they have garnered from the market. The funds raised will fuel their growth and innovation in the healthcare industry, further solidifying their position as a leading online marketing solution provider in China.
